ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Zeffix, Lösung zum Einnehmen - 240 ml
54869010 GlaxoSmithKline AG
Zeffix, Lösung zum Einnehmen24.03.1999
  24.03.1999
Lamivudine (J05AF05)28.10.2004
WHO-DDD 
08.03.240 ml
08.03. 
A  
Yes 
IPCI
27.75Yes
    
10 %46.60
7680548690104Synthetika
2117019 
Composition
lamivudinum 5 mg, saccharum 200 mg, propylenglycolum 20 mg, natrii citras dihydricus, acidum citricum, natrii hydroxidum aut acidum hydrochloridum, aqua, propylis parahydroxybenzoas 180 µg, E 218 1.5 mg, aromatica corresp. propylenglycolum 44.8 µg et alcohol benzylicus 0.02 µg, aromatica corresp. propylenglycolum 18.6 µg et alcohol benzylicus 0.01 µg, ad solutionem pro 1 ml corresp. natrium 2.94 mg.
Packungsbestandteile
Solution (oral) 
  
 
Active AgentDose
Lamivudine5 mg/ml
BAG: Active AgentDose
Lamivudine5 mg
 
Inactive agentsDoseadditional_information
Citric Acid  
Alcohol Benzylicus0.01 µg/ml 
Aqua  
Aromatica  
E 2181.5 mg/mlconserv.
Natrii Citras Dihydricus  
Natrii Hydroxidum aut Acidum Hydrochloridum  
Propylenglycol20 mg/ml 
Propylis Parahydroxybenzoas180 µg/ml 
Saccharum200 mg/ml 
 
Source
Data was imported : 04.06.2020 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home